Skip to main content
India Glycols Ltd logo

India Glycols Ltd — Investor Relations & Filings

Ticker · INDIAGLYCO ISIN · INE560A01023 LEI · 3358002YVDZUMPZLN823 BSE.NS Manufacturing
Filings indexed 1,575 across all filing types
Latest filing 2025-05-18 Regulatory Filings
Country IN India
Listing BSE.NS INDIAGLYCO

About India Glycols Ltd

https://www.indiaglycols.com/

India Glycols Ltd is a pioneer in the manufacturing of green technology-based chemicals. The company specializes in producing bio-based glycols, including monoethylene glycol (MEG), diethylene glycol (DEG), and triethylene glycol (TEG), utilizing renewable feedstock such as molasses. Its product portfolio extends to ethylene oxide derivatives, surfactants, and performance chemicals tailored for diverse applications in textiles, personal care, and oil and gas. Additionally, the company operates in the natural gums, industrial gases, and nutraceuticals sectors. IGL is recognized for its commitment to sustainable chemistry, being the first globally to commercialize the production of ethylene oxide and glycols from bio-ethanol. Its operations also include the production of extra neutral alcohol and high-quality spirits, serving both industrial and consumer markets with a focus on eco-friendly processes.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter from India Glycols Limited addressed to stock exchanges regarding the rescheduling of the Q4 & Full Year FY25 Earnings Conference Call. It mentions the new date and time for the call and includes an invite for the conference call with details of speakers from management. The document does not contain any financial data or results itself, but rather is an announcement about the timing of the earnings call. According to the classification rules, announcements about conference calls are classified as Call Transcript (CT) only if they contain the full transcript. Since this document is only an announcement and invite for the call, it is best classified as a Regulatory Filing (RNS) because it is a regulatory disclosure under SEBI regulations about the scheduling of an earnings call, and does not contain the actual earnings release or transcript.
2025-05-18 English
Please find attached.
Regulatory Filings
2025-05-16 English
Please find attached.
Regulatory Filings
2025-05-16 English
Please find attached
Regulatory Filings
2025-05-16 English
Dividend
Regulatory Filings
2025-05-16 English
Please find attached.
Regulatory Filings
2025-05-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.